A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Thursday. Specifically, these funds bought roughly $15 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these ETFs were down on Thursday.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 698,931 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 1,426,097 shares. At Thursday’s closing price, this would have valued the sales at roughly $14.7 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 46% and the other is down 38% in the past year.
Check out all the ARK Invest purchases for Thursday as well:
|ARKG||BNR||BURNING ROCK BIOTECH||4,000|
|ARKK||ZM||ZOOM VIDEO COMMUNICATIONS||43,550|
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.